Ophthalmic Lasers Market to Reach $2.94B by 2035 as Ocular Disorders Surge

Rising prevalence of eye conditions like glaucoma and AMD drives global industry expansion.

Apr. 6, 2026 at 10:18am

Got story updates? Submit your updates here. ›

The global ophthalmic lasers market is projected to grow from $1.72 billion in 2025 to $2.94 billion by 2035, driven by the increasing incidence of age-related eye diseases like cataracts, glaucoma, and macular degeneration. The U.S. market is expected to reach $1.14 billion by 2035, supported by a high density of ophthalmologists, established ambulatory surgery centers, and extensive insurance coverage.

Why it matters

As the world's population ages, the rising prevalence of vision-impairing conditions will significantly increase demand for laser-based ophthalmic treatments. This growth presents opportunities for medical device companies to innovate and expand access to advanced laser technologies that can improve outcomes for millions of patients.

The details

Femtosecond lasers held the largest revenue share of 31.74% in 2025, driven by adoption in premium cataract surgery and corneal procedures. Photocoagulation lasers captured 43.18% of the market, used widely to treat diabetic retinopathy and macular degeneration. The SLT laser segment is projected to see the highest growth at 6.84% CAGR as it gains traction as a first-line glaucoma treatment.

  • The global ophthalmic lasers market was valued at $1.72 billion in 2025.
  • The market is expected to reach $2.94 billion by 2035, growing at a CAGR of 5.52% from 2026-2035.
  • The U.S. ophthalmic lasers market was worth $0.67 billion in 2025 and is forecast to hit $1.14 billion by 2035, growing 5.50% annually.

The players

Alcon Inc.

A leading global medical device company that develops and markets ophthalmic surgical and vision care products, including advanced laser systems.

Carl Zeiss Meditec AG

A German medical technology company that produces a wide range of ophthalmic diagnostic and surgical devices, including femtosecond lasers for refractive and cataract procedures.

Got photos? Submit your photos here. ›

The takeaway

As the world's population ages and vision-impairing conditions become more prevalent, the ophthalmic lasers market is poised for significant growth. Medical device companies that can innovate and expand access to advanced laser technologies will be well-positioned to capitalize on this trend and improve outcomes for millions of patients.